NDC product
Moexipril Hydrochloride and Hydrochlorothiazide
NDC 0093-5214 · Teva Pharmaceuticals USA, Inc.
Key facts
| Product NDC | 0093-5214 |
|---|---|
| Proprietary name | Moexipril Hydrochloride and Hydrochlorothiazide |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Marketing category | ANDA |
| Application number | ANDA076980 |
| Marketing start | Mar 7, 2007 |
| Marketing end | Nov 30, 2019 |
| Listing certified through | Nov 30, 2019 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: